| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.007 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |